Deloitte: Proactive Care Could Unlock $527B in U.S. Women's Health Spending
New York – – September 29, 2026 -- Deloitte analysis projects that shifting U.S. healthcare from reactive treatment to proactive, life-stage-aware care could generate $527 billion in additional potential spending on women's health by 2030 compared with a baseline trajectory.
Deloitte models a 20-year health span gain from earlier intervention
Under a prevention and improved disease-management scenario, Deloitte's actuarial Future of Health model — built on five years of medical and pharmacy claims data from nearly 60 million lives — estimates women's health span could increase by up to 20 years in the long run. The firm's report, "How a $527 billion growth opportunity in women's health can improve health outcomes," compares a baseline 2030 spending trajectory against a scenario emphasizing earlier detection and management across 22 disease states.